title: Keloid scars and treatment with Botulinum Toxin Type A: the Belfast experience.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Robinson
authors.forename: Muhammad F
authors.initials: MF
authors.lastname: Khadim
authors.forename: Khalid
authors.initials: K
authors.lastname: Khan
mesh_terms: D000293:Adolescent; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002648:Child; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015552:Injections, Intralesional; D007627:Keloid / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D019274:Botulinum Toxins, Type A